Search All Jobs

Showing 3 of 3 Jobs

Lead Consultant - AI Platform Engineer

Chennai, Tamil Nadu, India

SAP Technical Specialist

Chennai, Tamil Nadu, India

Senior SAP Basis Consultant

Chennai, Tamil Nadu, India

Full-Time

Lead Consultant

AI Platform Engineer

Confirmed live in the last 24 hours

AstraZeneca

AstraZeneca

10,001+ employees

Develops and commercializes prescription medicines

No salary listed

Senior, Expert

Chennai, Tamil Nadu, India

In-person working gives us the platform we need to connect, work at pace and challenge perceptions. We work, on average, a minimum of three days per week from the office.

Category
DevOps & Infrastructure
Platform Engineering
Cloud Engineering
DevOps Engineering
Required Skills
Kubernetes
Python
Git
Machine Learning
Docker
AWS
Terraform
Ansible
Data Analysis
Requirements
  • Significant experience with AWS cloud environments is essential.
  • Knowledge of SageMaker, Athena, S3, EC2, RDS, Glue, Lambda, Step functions, EKS, and ECS is also essential.
  • Certification in appropriate areas will be viewed favourably.
  • Modern DevOps mindset, using best-of-breed DevOps toolchains, such as Docker and Git.
  • Experience with infrastructure as code technology such as Ansible, Terraform and Cloud Formation.
  • Strong software coding skills, with proficiency in Python, however exceptional ability in any language, will be recognized.
  • Experience managing an enterprise platform and service, handling new customer demand and feature requests.
  • Experience with containers and microservice architectures e.g., Kubernetes, Docker and serverless approaches.
  • Experience with Continuous Integration and building continuous delivery pipelines, such as CodePipeline, CodeBuild, and Code Deploy.
  • GxP experience.
  • Excellent communication, analytical and problem-solving skills.
Responsibilities
  • Provide the vital infrastructure and platform to support the deployment and monitoring of ML solutions in production Optimizing solutions for performance and scalability.
  • Collaborate closely with data science teams in developing cutting edge data science, AI/ML environments and workflows on AWS.
  • Liaise with R&D data scientists to understand their challenges and work with them to help productionise ML pipelines, models, and algorithms for innovative science.
  • Take responsibility for all aspects of software engineering, from design to implementation, QA and maintenance.
  • Lead technology processes from concept development to completion of project deliverables.
  • Liaise with other teams to enhance our technological stack, to enable the adoption of the latest advances in Data Processing and AI.
  • Team recruitment, training provision and coaching.
Desired Qualifications
  • Experience building large scale data processing pipelines. e.g., Hadoop/Spark and SQL.
  • Use of Data Science modelling tools e.g., R, Python and Data Science notebooks (e.g., Jupyter).
  • Multi cloud experience (AWS/Azure/GCP).
  • Demonstrable knowledge of building MLOPs environments to a production standard.
  • Experience on mentoring, coaching and supporting less experienced colleagues and clients.
  • Experience with SAFe agile principles and practices.

AstraZeneca focuses on discovering, developing, and selling prescription medicines. The company specializes in three main areas: Oncology, which deals with cancer treatment; Cardiovascular, Renal & Metabolism, which addresses heart, kidney, and metabolic diseases; and Respiratory & Immunology, which targets lung and immune system diseases. Their products are developed through extensive research and development, followed by clinical trials and regulatory approvals before reaching the market. AstraZeneca distinguishes itself from competitors by investing heavily in scientific research and fostering collaborations through initiatives like their Open Innovation program, which shares resources with the scientific community to speed up drug discovery. The company's goal is to advance healthcare by creating effective treatments for serious diseases and expanding their product offerings through strategic partnerships.

Company Size

10,001+

Company Stage

IPO

Headquarters

Cambridge, United Kingdom

Founded

1913

Simplify Jobs

Simplify's Take

What believers are saying

  • AI-driven drug discovery enhances AstraZeneca's R&D efficiency.
  • Real-world evidence streamlines AstraZeneca's drug approval processes.
  • Personalized medicine aligns with AstraZeneca's focus on precision therapies.

What critics are saying

  • Class-action lawsuit over Soliris could lead to financial penalties.
  • AI tool for breast cancer screening may face effectiveness challenges.
  • Foreign investment regulations in France may impact Dunkirk expansion.

What makes AstraZeneca unique

  • AstraZeneca excels in oncology, cardiovascular, and respiratory therapy areas.
  • The A.Catalyst Network fosters global collaboration and innovation in healthcare.
  • Open Innovation program accelerates drug discovery through shared resources.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Flexible Work Hours

Company News

Cision
Apr 22nd, 2025
Enhertu Combination Improved Pfs In 1L Her2+ Mbc

Enhertu combination improved PFS in 1L HER2+ mBC

Life Sciences IP Review
Apr 17th, 2025
AstraZeneca unit faces class-action suit over alleged Soliris monopoly

AstraZeneca unit faces class-action suit over alleged soliris monopoly.

Our Health Needs
Apr 11th, 2025
Study: Racial, ethnic minorities are underrepresented in AI mammogram interpretation

In 2024, AI biotech company Owkin partnered with pharma giant AstraZeneca to develop an AI-powered tool designed to pre-screen for gBRCA mutations (gBRCAm) in breast cancer directly from digitized pathology slides.

Medical Update Online
Apr 11th, 2025
AstraZeneca showcases progress in immunisation and real-world evidence addressing global infectious disease burden at ESCMID Global 2025

AstraZeneca showcases progress in immunisation and real-world evidence addressing global infectious disease burden at ESCMID Global 2025.

Cision
Apr 11th, 2025
Result Of Agm

11 April 2025Results of Annual General Meeting held on 11 April 2025AstraZeneca PLC announced the results of the voting at its Annual General Meeting (AGM) today. As proposed in the Notice of AGM, all Resolutions were decided by poll vote. Resolutions 9 - 12 were passed as special resolutions; all other resolutions were passed as ordinary resolutions.Resolution. Votes for. % of votes cast